Acetylsalicylic acid - Bayer
Alternative Names: Acetylsalicylic acid; BAYE-004465; UI-1610477; UI-1615160Latest Information Update: 28 Jan 2025
Price :
$50 *
At a glance
- Originator Bayer
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Unspecified
Most Recent Events
- 13 Nov 2024 Preclinical trials in Unspecified in Germany (PO), before November 2024
- 24 Oct 2024 Bayer plans a phase I pharmacokinetics trial (In volunteers) in Mexico in November 2024 (NCT06655194)